Sickle Cell Disease, Hemechip

CompletedOBSERVATIONAL
Enrollment

738

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

April 26, 2018

Study Completion Date

April 26, 2018

Conditions
Sickle Cell Disease
Trial Locations (7)

27599

University of North Carolina at Chapel Hill, Chapel Hill

44106

Case Western Reserve University, Cleveland

University Hospitals Cleveland Medical Center, Cleveland

68198

University of Nebraska Medical Center, Omaha

Unknown

Aminu Kano Teaching Hospital, Kano

Hasiya Bayero Pediatric Hospital, Kano

Murtala Mohammed Specialist Hospital, Kano

All Listed Sponsors
collaborator

US federal government

UNKNOWN

collaborator

University of Nebraska

OTHER

collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

Case Western Reserve University

OTHER

collaborator

Aminu Kano Teaching Hospital, Nigeria

UNKNOWN

collaborator

Murtala Muhammad Specialist Hospital, Nigeria

UNKNOWN

collaborator

Hasiya Bayero Hospital, Nigeria

UNKNOWN

lead

University Hospitals Cleveland Medical Center

OTHER

NCT03948516 - Sickle Cell Disease, Hemechip | Biotech Hunter | Biotech Hunter